Aardvark Therapeutics (AARD) Institutional Ownership $10.01 -1.11 (-9.98%) As of 05/22/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Aardvark Therapeutics (NASDAQ:AARD)Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$41.30MNumber ofInstitutional Sellers(last 12 months)0 Get AARD Insider Trade Alerts Want to know when executives and insiders are buying or selling Aardvark Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AARD Institutional Buying and Selling by Quarter Aardvark Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Goldman Sachs Group Inc.20,311$153K0.0%N/A0.094% 5/16/2025 Cormorant Asset Management LP800,189$6.01M0.5%N/A3.688% 5/16/2025 Adage Capital Partners GP L.L.C.250,000$1.88M0.0%N/A1.152% 5/15/2025 Braidwell LP500,000$3.76M0.1%N/A2.305% 5/14/2025 Walleye Capital LLC11,730$88K0.0%N/A0.054% 5/8/2025 Decheng Capital LLC3,917,299$29.42M8.3%N/A18.055% (Data available from 1/1/2016 forward) AARD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AARD shares? During the previous two years, the following institutional investors and hedge funds held shares of Aardvark Therapeutics shares: Decheng Capital LLC ($29.42M), Cormorant Asset Management LP ($6.01M), Braidwell LP ($3.76M), Adage Capital Partners GP L.L.C. ($1.88M), and Goldman Sachs Group Inc. ($153K), Walleye Capital LLC ($88K).Learn more on AARD's institutional investors. Which institutional investors have been buying Aardvark Therapeutics stock? The following institutional investors have purchased Aardvark Therapeutics stock in the last 24 months: Decheng Capital LLC ($3.92M), Cormorant Asset Management LP ($800.19K), Braidwell LP ($500K), Adage Capital Partners GP L.L.C. ($250K), Goldman Sachs Group Inc. ($20.31K), and Walleye Capital LLC ($11.73K). How much institutional buying is happening at Aardvark Therapeutics? Institutional investors have bought a total of 5,499,529 shares in the last 24 months. This purchase volume represents approximately $41.30M in transactions. Related Companies LENZ Major Shareholders SNDX Major Shareholders CVAC Major Shareholders NUVB Major Shareholders PRAX Major Shareholders XERS Major Shareholders QURE Major Shareholders NRIX Major Shareholders RCKT Major Shareholders AVXL Major Shareholders This page (NASDAQ:AARD) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aardvark Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aardvark Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AARD Stock Free AARD Stock Alerts